The measurement of serum transferrin receptor.
The concentration of the soluble fragment of transferrin receptor in serum is an important new hematological parameter. Clinical and laboratory studies have shown that this serum form of the receptor reflects the total body mass of cellular transferrin receptor, 80% of which is contained in the erythroid marrow. The two disorders that result in an elevation in the serum transferrin receptor are anemias associated with enhanced erythropoiesis and tissue iron deficiency. The concentration of soluble transferrin receptor provides a useful quantitative measure of the erythroid marrow mass and thereby assists clinically in categorizing the type of anemia. The most important clinical use of the serum transferrin receptor is in determining the cause of iron deficient erythropoiesis (that is, identifying iron deficiency anemia whether it occurs alone or in the presence of the anemia of chronic disease). Present evidence supports the routine use of the serum transferrin receptor in the clinical evaluation of anemic patients.
Cook
J D
JD
Department of Medicine, University of Kansas Medical Center, Kansas City 66160, USA.
D000740:Anemia / Q000175:diagnosis / Q000209:etiology; D018798:Anemia, Iron-Deficiency / Q000175:diagnosis*; D002908:Chronic Disease; D003937:Diagnosis, Differential; D004920:Erythropoiesis; D006801:Humans; D000090463:Iron Deficiencies; D011990:Receptors, Transferrin / Q000097:blood* / Q000378:metabolism
D011990:Receptors, Transferrin